To start your customized experience click the start button
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
CURE Communications Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
The Food and Drug Administration (FDA) granted priority review to the combination use of Darzalex (daratumumab), Velcade (bortezomib), melphalan and prednisone for the treatment of newly diagnosed patients with multiple myeloma who are not eligible for autologous stem cell transplant (ACST).
Mindy Waizer
The third week in January is national Teen Cancer Awareness Week, a time to shine light on the unique medical, emotional and psychosocial needs of teens with cancer. But one organization focuses on these concerns year-round: Teen Cancer America (TCA).
Brielle Urciuoli
While the treatment of leukemia has greatly advanced since 1946, so has the organization. In the past seven decades, LRF has raised more than $75 million for its mission of conquering not only leukemia, but all blood cancers.


Barbara Tako
Breast cancer survivor speculates about achieving health and wonders what "healthy" even means. Is the game rigged?
Khevin Barnes
It's sometimes easy to think that our bodies have failed us, but we need all the help we can get.
Kim Johnson
A vast majority of my friends and the people that I know are in the field of nursing. Because of this, the phrase, “just a nurse” isn't one that I hear very often. That being said, I was having a conversation the other day and that sentence set my ears on fire. I was immediately taken aback by the sheer ignorance that I had been privy to.

CURE Conections®

Philippa Cheetham, MD; Sara F. Martin, MD; and Evan C. Osmundson, MD, PhD, remark on recent improvements in managing advanced lung cancer, and offer insight regarding future therapies that show promise.
Philippa Cheetham, MD; Sara F. Martin, MD; Evan C. Osmundson, MD, PhD; and Leora Horn, MD, MSc, reflect on common challenges faced while treating advanced lung cancer and discuss their considerations for creating long-term treatment plans.
Philippa Cheetham, MD; Sara F. Martin, MD; and Leora Horn, MD, MSc, discuss how they counsel patients on strategies for managing side effects from newer therapies in advanced lung cancer.


Radhakrishnan Ramchandren, M.D.
Radhakrishnan Ramchandren, M.D., from the Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, discusses the role of clinical trials in developing news drugs and standards of care for patients with lymphoma.
Marina Chiara Garassino, M.D.
Marina Chiara Garassino, M.D., talks about how immunotherapy agents have vastly improved the treatment field of patients with non-small cell lung cancer.
Carole Brennan Miller, M.D.
Carole Brennan Miller, M.D., head of the Cancer Institute at Saint Agnes Hospital, explains what makes people with myeloproliferative neoplasms (MPNs) unique, and why she finds it interesting to work with them.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable